K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes

  1. Y Hattori,
  2. H Odagiri,
  3. H Nakatani,
  4. K Miyagawa,
  5. K Naito,
  6. H Sakamoto,
  7. O Katoh,
  8. T Yoshida,
  9. T Sugimura, and
  10. M Terada
  1. Genetics Division, National Cancer Center Research Institute, Tokyo, Japan.

Abstract

DNA fragments amplified in a stomach cancer-derived cell line, KATO-III, were previously identified by the in-gel DNA renaturation method, and a 0.2-kilobase-pair fragment of the amplified sequence was subsequently cloned. By genomic walking, a portion of the exon of the gene flanking this 0.2-kilobase-pair fragment was cloned, and the gene was designated as K-sam (KATO-III cell-derived stomach cancer amplified gene). The K-sam cDNAs, corresponding to the 3.5-kilobase K-sam mRNA, were cloned from the KATO-III cells. Sequence analysis revealed that this gene coded for 682 amino acid residues that satisfied the characteristics of the receptor tyrosine kinase. The K-sam gene had significant homologies with bek, FLG, and chicken basic fibroblast growth factor receptor gene. The K-sam gene was amplified in KATO-III cells with the major transcript of 3.5-kilobases in size. This gene was also expressed in some other stomach cancer cells, a small cell lung cancer, and germ cell tumors.

« Previous | Next Article »Table of Contents